Panacea GTM brain

category

market profile

• text: Biotech and device sponsors need pathway strategy, FDA meeting preparation and submission authoring while managing development timelines and budget.
• text: The market includes consultant-led services and software for regulatory affairs; a service model may suit teams without regulatory staff.

personas

• title: Biotech founder or CEO
  pains:

  • Regulatory delays consume runway before clinical progress or commercialization
  • Hourly advisory engagements are difficult to budget
  • Small teams lack specialized FDA submission expertise
• title: VP regulatory affairs at a medical device company
  pains:

  • Choosing among 510(k), De Novo and PMA pathways
  • Coordinating expert review and authoring under a deadline
  • Ensuring the accuracy of AI-assisted material
• title: Clinical development leader
  pains:

  • Preparing for FDA meetings while coordinating the development program
  • Translating evidence into an appropriate submission package

icp

• text: Biotech sponsors preparing IND, NDA or BLA work who need external regulatory strategy and submission support.
• text: Medical device developers pursuing US clearance or approval, especially lean teams that need end-to-end consultant support.

message pillars

• text: Combine regulatory specialists with AI.
• text: Provide predictable fixed pricing.
• text: Support customers across the regulatory process.
• text: Keep expert oversight throughout the work.

objections

• objection: Can AI-assisted work meet FDA quality expectations?
  response: Evaluate the named experts, their pathway experience, review controls and final submission responsibility.
• objection: Will a fixed price cover unexpected work?
  response: Agree on the deliverables, milestone definitions, exclusions and change-order terms in advance.
• objection: Can the team handle our specific device or therapeutic area?
  response: Use the consultation to verify relevant submission experience and assess the proposed pathway.

competitors

• name: Complizen
  why: Offers AI-supported consulting for medical device regulatory submissions.
• name: Emergo by UL
  why: Provides FDA regulatory consulting and 510(k) support for device companies.
• name: Rimsys
  why: Regulatory information software with AI capabilities is an alternative for teams bringing more workflow in-house.
• name: Parexel
  why: Regulatory consulting provider partnering with Weave Bio on AI-assisted submissions.

influencers

• name: Haris Javed-Akhtar
  url: https://www.ycombinator.com/companies/panacea
  why: Founder and CEO explains the fixed-milestone regulatory service model.

keywords

• FDA regulatory consulting
• 510k submission consultant
• IND regulatory consultant
• FDA De Novo submission support
• biotech regulatory strategy
• FDA submission fixed price
• AI medical device regulatory

voice

• confident and clinical
• outcome-focused
• expert-led

signals

• text: A biotech is preparing an IND or approaching an FDA meeting without a full regulatory team.
• text: A device developer is entering a 510(k), De Novo or PMA submission cycle and seeks external capacity.

pricing

motion

channels

• founder referrals
• LinkedIn
• website consultations

confidence

Founders

• name: Haris Javed-Akhtar
  title: Founder/CEO
  role: CEO
  bio: ex-GTM (Partnerships Lead) @ Anterior - backed by Sequoia, NEA and Microsoft AI's CEO. MD, Imperial College Medical School, Imperial College Business School.
• name: Yaman Ziadeh
  title: Founder/CTO
  role: CTO
  bio: Ex-AI Platform Engineer @ Anterior - backed by Sequoia, NEA and Microsoft AI's CEO. MS in AI from University of Illinois, Chicago. Ex-Software Engineer @ Bloomberg on the NoSQL data Infrastructure Team. Co-founded & bootstrapped Baqi, scaled to $5M+ in transactions with 20+ enterprise partnerships.